NEW YORK (Reuters Health) Jun 10 –
The incidence of esophageal candidiasis in HIV-infected adults has declined since the advent of highly active antiretroviral therapy (HAART) and results of a new study show a similar trend in HIV-infected children, with one caveat.
According to Dr. Thomas J. Walsh of the National Cancer Institute in Bethesda and colleagues, esophageal candidiasis persists in a subgroup of children with HIV infection who fail to respond to HAART. These children may present without concurrent oropharyngeal candidiasis or other typical clinical symptoms.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!